Exagen (XGN) Cash from Financing Activities (2018 - 2026)
Exagen (XGN) posted Cash from Financing Activities of -$62000.0 for Q1 2026, up 83.85% quarter-over-quarter from -$384000.0 in Q4 2025, and up 3.12% year-on-year from -$60121.2 in Q1 2025.
Exagen (XGN) Cash from Financing Activities (2018 - 2026) Analysis & Trends
Exagen (XGN) has reported Cash from Financing Activities for 9 consecutive years, with -$62000.0 the latest figure, recorded in Q1 2026.
- Cash from Financing Activities for Q1 2026 came in at -$62000.0, up 3.12% year-over-year; the trailing twelve-month figure through Mar 2026 was $24.4 million (up 3997.45% YoY), and the FY2025 annual result was $24.4 million, up 3785.52% from the prior year.
- Cash from Financing Activities was -$62000.0 for Q1 2026 at Exagen, up from -$384000.0 in the prior quarter.
- Over five years, Cash from Financing Activities peaked at $21.9 million in Q2 2025 and troughed at -$10.2 million in Q2 2023.
- Average Cash from Financing Activities over 5 years is $740529.4, with a median of -$108000.0 recorded in 2023.
- Year-over-year, Cash from Financing Activities slumped 3779.55% in 2023 and jumped 9804.87% in 2025.
- Over 5 years, Cash from Financing Activities stood at -$173000.0 in 2022, then dropped by 27.17% to -$220000.0 in 2023, then advanced by 1.82% to -$216000.0 in 2024, then slumped by 77.78% to -$384000.0 in 2025, then soared by 83.85% to -$62000.0 in 2026.
- Per Business Quant data, the three most recent Cash from Financing Activities figures were -$62000.0 in Q1 2026, -$384000.0 in Q4 2025, and $2.9 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Financing (Qtr) |
|---|---|---|---|---|---|
| 1 | Waters | 31,055.11 Bn | 31,054.65 Bn | 1.11 Bn | -213.00 Mn |
| 2 | Thermo Fisher Scientific | 191.02 Bn | 187.77 Bn | 7.74 Bn | 1.09 Bn |
| 3 | Danaher | 137.16 Bn | 131.47 Bn | 3.59 Bn | 46.00 Mn |
| 4 | Idexx Laboratories | 42.82 Bn | 42.62 Bn | 722.74 Mn | -211.43 Mn |
| 5 | Natera | 39.09 Bn | 37.99 Bn | 696.04 Mn | 3.76 Mn |
| 6 | Agilent Technologies | 37.61 Bn | 35.81 Bn | 990.00 Mn | -144.00 Mn |
| 7 | Iqvia Holdings | 34.23 Bn | 32.25 Bn | 1.36 Bn | -433.00 Mn |
| 8 | Illumina | 28.14 Bn | 26.98 Bn | 721.00 Mn | -251.00 Mn |
| 9 | Mettler Toledo International | 26.40 Bn | 26.33 Bn | 555.82 Mn | -114.33 Mn |
| 10 | Exagen | 112.36 Mn | 90.84 Mn | 10.21 Mn | -62,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -62,000.00 |
| Mar 31, 2026 | -62,000.00 |
| Dec 31, 2025 | -384,000.00 |
| Dec 31, 2025 | -384,000.00 |
| Sep 30, 2025 | 2.95 Mn |
| Sep 30, 2025 | 2.95 Mn |
| Jun 30, 2025 | 21.93 Mn |
| Jun 30, 2025 | 21.93 Mn |
| Mar 31, 2025 | -64,000.00 |
| Mar 31, 2025 | -64,000.00 |
| Dec 31, 2024 | -216,000.00 |
| Dec 31, 2024 | -216,000.00 |
| Sep 30, 2024 | -121,000.00 |
| Sep 30, 2024 | -121,000.00 |
| Jun 30, 2024 | -226,000.00 |
| Jun 30, 2024 | -226,000.00 |
| Mar 31, 2024 | -100,000.00 |
| Mar 31, 2024 | -100,000.00 |
| Dec 31, 2023 | -220,000.00 |
| Dec 31, 2023 | -220,000.00 |